Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v8-EN
Language English English
Date Updated 2023-07-07 2021-01-02
Drug Identification Number 02023695 02023695
Brand name ATROPINE ATROPINE
Common or Proper name Atropine Sulfate Atropine Sulfate
Company Name PHARMA STULLN INC. PHARMA STULLN INC.
Ingredients ATROPINE SULFATE ATROPINE SULFATE
Strength(s) 1% 1%
Dosage form(s) SOLUTION SOLUTION SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC OPHTHALMIC OPHTHALMIC
Packaging size 15ml bottle 15ml bottle
ATC code S01FA S01FA
ATC description MYDRIATICSAND CYCLOPLEGICS MYDRIATICSAND CYCLOPLEGICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-11-01 2020-11-01
Estimated end date 2023-07-30 2021-01-04
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments